Compare EVMN & MOVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EVMN | MOVE |
|---|---|---|
| Founded | 2020 | 2018 |
| Country | United States | United States |
| Employees | 48 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 825.5M | 901.4M |
| IPO Year | N/A | 2021 |
| Metric | EVMN | MOVE |
|---|---|---|
| Price | $22.78 | $19.54 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $43.88 | N/A |
| AVG Volume (30 Days) | ★ 288.0K | 52.3K |
| Earning Date | 06-11-2026 | 04-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $433,000.00 |
| Revenue This Year | N/A | $1,460.71 |
| Revenue Next Year | N/A | $96.77 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $13.89 | $0.51 |
| 52 Week High | $33.20 | $34.87 |
| Indicator | EVMN | MOVE |
|---|---|---|
| Relative Strength Index (RSI) | 42.32 | 63.82 |
| Support Level | $21.39 | $6.27 |
| Resistance Level | $23.08 | $20.04 |
| Average True Range (ATR) | 1.56 | 1.82 |
| MACD | -0.20 | 0.51 |
| Stochastic Oscillator | 20.44 | 76.64 |
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.
Corvex Inc is an AI cloud computing company specializing in GPU accelerated infrastructure for AI workloads. The company provides AI-focused computing infrastructure that offers scalable computational resources. Its platform uses GPU-accelerated compute clusters and high-throughput storage to support performance, security, and efficiency at scale. The company's product portfolio includes GPU Clusters, Inference-as-a-Service, Confidential Computing, and GPU Node.